Tahseen Hamamyh
Tahseen Hamamyh publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Hematology, on topics such as Diabetes Treatment and Management, Hyperglycemia and glycemic control in critically ill and hospitalized patients and Heart Failure Treatment and Management.
- World rank
- #5,720,665 of 7,710,434 ranked researchers
- Rank in Qatar
- #2,866 of 3,423
- Works
- 17
- Citations
- 72
- Citations per work
- 4.2
What does Tahseen Hamamyh research?
Tahseen Hamamyh's work is mostly in Medicine (71%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1270.9%
- Medicine1270.9%
- Everything else529.1%
- 1Cardiology and Cardiovascular Medicine25% of their works
- 2Endocrinology, Diabetes and Metabolism19% of their works
- 3Hematology8% of their works
- 4Surgery8% of their works
- 5Genetics6% of their works
- 6Physiology4% of their works
Research topics
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Heart Failure Treatment and Management
- Chronic Lymphocytic Leukemia Research
- Cardiovascular Function and Risk Factors
- Chronic Myeloid Leukemia Treatments
- Potassium and Related Disorders
- Genetics and Neurodevelopmental Disorders
Which keywords describe Tahseen Hamamyh's research?
The keywords of their largest research topics: Heart Failure, Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Critical Care, Hyperglycemia, Type 2 Diabetes and Chronic Lymphocytic Leukemia.
- Fragile X Syndrome
- Imatinib
- Echocardiography
- BCR-ABL
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Hyperglycemia
- Cardiovascular Outcomes
- Glycemic Control
- Heart Failure
- Insulin Therapy
- Critical Care
- Type 2 Diabetes
- Diagnosis
- Guidelines
- Chamber Quantification
- Hyperkalemia
- Renin-Angiotensin-Aldosterone System Inhibitors
- Rett Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Heart Failure114 topics
- Glycemic Control82 topics
- Insulin Therapy82 topics
- Cardiovascular Outcomes41 topic
- Critical Care41 topic
- Hyperglycemia41 topic
- Type 2 Diabetes41 topic
- Chronic Lymphocytic Leukemia31 topic
- Diagnosis31 topic
- Genomic Aberrations31 topic
- Guidelines31 topic
- BCR-ABL21 topic
- Chamber Quantification21 topic
- Echocardiography21 topic
- Hyperkalemia21 topic
- Imatinib21 topic
- Renin-Angiotensin-Aldosterone System Inhibitors21 topic
- Fragile X Syndrome11 topic
- Rett Syndrome11 topic
Where does Tahseen Hamamyh work?
Tahseen Hamamyh's main affiliation in the publication record is Hamad Medical Corporation, Qatar.
How many publications and citations does Tahseen Hamamyh have?
OpenAlex counts 17 works and 72 citations for Tahseen Hamamyh, an h-index of 3, ranking #5,720,665 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tahseen Hamamyh. Posts are plain text and can be reported.